Yang Huang
Stock Analyst at J.P. Morgan
(4.83)
# 429
Out of 4,692 analysts
121
Total ratings
72.6%
Success rate
38.1%
Average return
Main Sectors:
Stocks Rated by Yang Huang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1801 Innovent Biologics, Inc. | Maintained: Buy | $117.00 → $140.00 | $101.80 | +37.52% | 20 | Aug 27, 2026 | |
| HKG: 9995 RemeGen Co., Ltd. | Maintained: Buy | $129.00 | $79.05 | +63.19% | 14 | Aug 6, 2026 | |
| HKG: 2359 WuXi AppTec Co., Ltd. | Maintained: Buy | $138.00 → $150.00 | $188.00 | -20.21% | 11 | Mar 26, 2026 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Maintained: Buy | $499.00 → $545.00 | $481.80 | +13.12% | 2 | Nov 24, 2025 | |
| HKG: 1877 Shanghai Junshi Biosciences Co., Ltd. | Maintained: Sell | $18.00 → $20.00 | $17.64 | +13.38% | 9 | Oct 30, 2025 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Maintained: Sell | $37.00 → $38.00 | $39.76 | -4.43% | 8 | Oct 29, 2025 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Initiated Coverage: Buy | $43.00 | $34.40 | +25.00% | 1 | Sep 25, 2025 | |
| HKG: 1276 Jiangsu Hengrui Pharmaceuticals Co.,Ltd | Initiated Coverage: Hold | $78.00 | $46.08 | +69.27% | 1 | Sep 23, 2025 | |
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $99.00 → $166.00 | $86.00 | n/a | 11 | Aug 27, 2025 | |
| HKG: 1548 Genscript Biotech Corporation | Maintained: Buy | $16.00 → $24.00 | $36.80 | n/a | 2 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36.00 → $37.00 | $49.56 | n/a | 10 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46.00 → $74.00 | $70.25 | n/a | 6 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52.00 → $93.00 | $32.42 | n/a | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $84.00 → $80.00 | $36.32 | n/a | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $186.00 → $183.60 | $212.60 | n/a | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3.40 | $2.04 | n/a | 1 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $217 → $64 | $25.46 | n/a | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4.80 → $3.00 | $1.90 | n/a | 3 | Jan 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26.50 | $6.39 | n/a | 1 | Jan 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14.00 | $9.22 | n/a | 4 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18.00 | $10.88 | n/a | 2 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $9.00 → $11.00 | $16.01 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $230 → $169 | $359.58 | n/a | 4 | Mar 26, 2020 |
Innovent Biologics, Inc.
Aug 27, 2026
Maintained: Buy
Price Target: $117.00 → $140.00
Current: $101.80
Upside: +37.52%
RemeGen Co., Ltd.
Aug 6, 2026
Maintained: Buy
Price Target: $129.00
Current: $79.05
Upside: +63.19%
WuXi AppTec Co., Ltd.
Mar 26, 2026
Maintained: Buy
Price Target: $138.00 → $150.00
Current: $188.00
Upside: -20.21%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Nov 24, 2025
Maintained: Buy
Price Target: $499.00 → $545.00
Current: $481.80
Upside: +13.12%
Shanghai Junshi Biosciences Co., Ltd.
Oct 30, 2025
Maintained: Sell
Price Target: $18.00 → $20.00
Current: $17.64
Upside: +13.38%
Hangzhou Tigermed Consulting Co., Ltd
Oct 29, 2025
Maintained: Sell
Price Target: $37.00 → $38.00
Current: $39.76
Upside: -4.43%
Hansoh Pharmaceutical Group Company Limited
Sep 25, 2025
Initiated Coverage: Buy
Price Target: $43.00
Current: $34.40
Upside: +25.00%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Sep 23, 2025
Initiated Coverage: Hold
Price Target: $78.00
Current: $46.08
Upside: +69.27%
Akeso, Inc.
Aug 27, 2025
Maintained: Buy
Price Target: $99.00 → $166.00
Current: $86.00
Upside: n/a
Genscript Biotech Corporation
Aug 21, 2025
Maintained: Buy
Price Target: $16.00 → $24.00
Current: $36.80
Upside: n/a
Aug 21, 2025
Maintained: Buy
Price Target: $36.00 → $37.00
Current: $49.56
Upside: n/a
Aug 14, 2025
Maintained: Buy
Price Target: $46.00 → $74.00
Current: $70.25
Upside: n/a
Aug 7, 2025
Maintained: Buy
Price Target: $52.00 → $93.00
Current: $32.42
Upside: n/a
May 16, 2023
Maintained: Buy
Price Target: $84.00 → $80.00
Current: $36.32
Upside: n/a
Mar 7, 2023
Maintained: Buy
Price Target: $186.00 → $183.60
Current: $212.60
Upside: n/a
Feb 22, 2023
Upgraded: Buy
Price Target: $3.40
Current: $2.04
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $217 → $64
Current: $25.46
Upside: n/a
Jan 6, 2022
Downgraded: Sell
Price Target: $4.80 → $3.00
Current: $1.90
Upside: n/a
Jan 6, 2022
Downgraded: Sell
Price Target: $26.50
Current: $6.39
Upside: n/a
Aug 31, 2021
Maintained: Buy
Price Target: $14.00
Current: $9.22
Upside: n/a
Aug 27, 2021
Maintained: Hold
Price Target: $18.00
Current: $10.88
Upside: n/a
Jun 29, 2021
Downgraded: Hold
Price Target: $9.00 → $11.00
Current: $16.01
Upside: n/a
Mar 26, 2020
Maintained: Buy
Price Target: $230 → $169
Current: $359.58
Upside: n/a